metoclopramide has been researched along with Chronic Progressive Multiple Sclerosis in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamal Omidi, S | 1 |
| Fernandez BacaVaca, G | 1 |
| Lacuey, N | 1 |
| Shaikh, AG | 1 |
| Morgan, M | 1 |
| Lhatoo, SD | 1 |
1 other study available for metoclopramide and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Episodic gaze deviation in multiple sclerosis - Versive seizures or oculogyric crises?
Topics: Adult; Antiemetics; Diagnosis, Differential; Drug Resistant Epilepsy; Dystonia; Electroencephalograp | 2018 |